Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling

Y. F. Wong, T. H. Cheung, K. W K Lo, S. F. Yim, N. S S Siu, S. C S Chan, T. W F Ho, K. W Y Wong, M. Y. Yu, V. W. Wang, C. Li, G. J. Gardner, T. Bonome, W. B. Johnson, David I Smith, T. K H Chung, M. J. Birrer

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Endometrial cancer is the third most common gynecologic malignancy and the ninth most common malignancy for females overall in Hong Kong. Approximately 80% or more of these cancers are endometrioid endometrial adenocarcinomas. The aim of this study was to reveal genes contributing to the development of endometrioid endometrial cancer, which may impact diagnosis, prognosis and treatment of the disease. Whole-genome gene expression analysis was completed for a set of 55 microdissected sporadic endometrioid endometrial adenocarcinomas and 29 microdissected normal endometrium specimens using the Affymetrix Human U133 Plus 2.0 oligonucleotide microarray. Selected genes of interest were validated by quantitative real-time-polymerase chain reaction (qRT-PCR). Pathway analysis was performed to reveal gene interactions involved in endometrial tumorigenesis. Unsupervised hierarchical clustering displayed a distinct separation between the endometrioid adenocarcinomas and normal endometrium samples. Supervised analysis identified 117 highly differentially regulated genes (≥4.0-fold change), which distinguished the endometrial cancer specimens from normal endometrium. Twelve novel genes including DKK4, ZIC1, KIF1A, SAA2, LOC16378, ALPP2, CCL20, CXCL5, BST2, OLFM1, KLRC1 and MBC45780 were deregulated in the endometrial cancer, and further validated in an independent set of 56 cancer and 29 normal samples using qRT-PCR. In addition, 10 genes were differentially regulated in late-stage cancer, as compared to early-stage disease, and may be involved in tumor progression. Pathway analysis of the expression data from this tumor revealed an interconnected network consisting of 21 aberrantly regulated genes involved in angiogenesis, cell proliferation and chromosomal instability. The results of this study highlight the molecular features of endometrioid endometrial cancer and provide insight into the events underlying the development and progression of endometrioid endometrial cancer.

Original languageEnglish (US)
Pages (from-to)1971-1982
Number of pages12
JournalOncogene
Volume26
Issue number13
DOIs
StatePublished - Mar 22 2007

Fingerprint

Hong Kong
Gene Expression Profiling
Endometrial Neoplasms
Genome
Endometrioid Carcinoma
Genes
Endometrium
Neoplasms
Real-Time Polymerase Chain Reaction
Chromosomal Instability
Oligonucleotide Array Sequence Analysis
Cluster Analysis
Carcinogenesis
Cell Proliferation
Gene Expression

Keywords

  • Endometrioid endometrial cancer
  • Gene expression profiling
  • Signaling pathway

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Wong, Y. F., Cheung, T. H., Lo, K. W. K., Yim, S. F., Siu, N. S. S., Chan, S. C. S., ... Birrer, M. J. (2007). Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene, 26(13), 1971-1982. https://doi.org/10.1038/sj.onc.1209986

Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. / Wong, Y. F.; Cheung, T. H.; Lo, K. W K; Yim, S. F.; Siu, N. S S; Chan, S. C S; Ho, T. W F; Wong, K. W Y; Yu, M. Y.; Wang, V. W.; Li, C.; Gardner, G. J.; Bonome, T.; Johnson, W. B.; Smith, David I; Chung, T. K H; Birrer, M. J.

In: Oncogene, Vol. 26, No. 13, 22.03.2007, p. 1971-1982.

Research output: Contribution to journalArticle

Wong, YF, Cheung, TH, Lo, KWK, Yim, SF, Siu, NSS, Chan, SCS, Ho, TWF, Wong, KWY, Yu, MY, Wang, VW, Li, C, Gardner, GJ, Bonome, T, Johnson, WB, Smith, DI, Chung, TKH & Birrer, MJ 2007, 'Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling', Oncogene, vol. 26, no. 13, pp. 1971-1982. https://doi.org/10.1038/sj.onc.1209986
Wong, Y. F. ; Cheung, T. H. ; Lo, K. W K ; Yim, S. F. ; Siu, N. S S ; Chan, S. C S ; Ho, T. W F ; Wong, K. W Y ; Yu, M. Y. ; Wang, V. W. ; Li, C. ; Gardner, G. J. ; Bonome, T. ; Johnson, W. B. ; Smith, David I ; Chung, T. K H ; Birrer, M. J. / Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. In: Oncogene. 2007 ; Vol. 26, No. 13. pp. 1971-1982.
@article{2497f297e8e649d0bd937b4f7ead1cc2,
title = "Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling",
abstract = "Endometrial cancer is the third most common gynecologic malignancy and the ninth most common malignancy for females overall in Hong Kong. Approximately 80{\%} or more of these cancers are endometrioid endometrial adenocarcinomas. The aim of this study was to reveal genes contributing to the development of endometrioid endometrial cancer, which may impact diagnosis, prognosis and treatment of the disease. Whole-genome gene expression analysis was completed for a set of 55 microdissected sporadic endometrioid endometrial adenocarcinomas and 29 microdissected normal endometrium specimens using the Affymetrix Human U133 Plus 2.0 oligonucleotide microarray. Selected genes of interest were validated by quantitative real-time-polymerase chain reaction (qRT-PCR). Pathway analysis was performed to reveal gene interactions involved in endometrial tumorigenesis. Unsupervised hierarchical clustering displayed a distinct separation between the endometrioid adenocarcinomas and normal endometrium samples. Supervised analysis identified 117 highly differentially regulated genes (≥4.0-fold change), which distinguished the endometrial cancer specimens from normal endometrium. Twelve novel genes including DKK4, ZIC1, KIF1A, SAA2, LOC16378, ALPP2, CCL20, CXCL5, BST2, OLFM1, KLRC1 and MBC45780 were deregulated in the endometrial cancer, and further validated in an independent set of 56 cancer and 29 normal samples using qRT-PCR. In addition, 10 genes were differentially regulated in late-stage cancer, as compared to early-stage disease, and may be involved in tumor progression. Pathway analysis of the expression data from this tumor revealed an interconnected network consisting of 21 aberrantly regulated genes involved in angiogenesis, cell proliferation and chromosomal instability. The results of this study highlight the molecular features of endometrioid endometrial cancer and provide insight into the events underlying the development and progression of endometrioid endometrial cancer.",
keywords = "Endometrioid endometrial cancer, Gene expression profiling, Signaling pathway",
author = "Wong, {Y. F.} and Cheung, {T. H.} and Lo, {K. W K} and Yim, {S. F.} and Siu, {N. S S} and Chan, {S. C S} and Ho, {T. W F} and Wong, {K. W Y} and Yu, {M. Y.} and Wang, {V. W.} and C. Li and Gardner, {G. J.} and T. Bonome and Johnson, {W. B.} and Smith, {David I} and Chung, {T. K H} and Birrer, {M. J.}",
year = "2007",
month = "3",
day = "22",
doi = "10.1038/sj.onc.1209986",
language = "English (US)",
volume = "26",
pages = "1971--1982",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "13",

}

TY - JOUR

T1 - Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling

AU - Wong, Y. F.

AU - Cheung, T. H.

AU - Lo, K. W K

AU - Yim, S. F.

AU - Siu, N. S S

AU - Chan, S. C S

AU - Ho, T. W F

AU - Wong, K. W Y

AU - Yu, M. Y.

AU - Wang, V. W.

AU - Li, C.

AU - Gardner, G. J.

AU - Bonome, T.

AU - Johnson, W. B.

AU - Smith, David I

AU - Chung, T. K H

AU - Birrer, M. J.

PY - 2007/3/22

Y1 - 2007/3/22

N2 - Endometrial cancer is the third most common gynecologic malignancy and the ninth most common malignancy for females overall in Hong Kong. Approximately 80% or more of these cancers are endometrioid endometrial adenocarcinomas. The aim of this study was to reveal genes contributing to the development of endometrioid endometrial cancer, which may impact diagnosis, prognosis and treatment of the disease. Whole-genome gene expression analysis was completed for a set of 55 microdissected sporadic endometrioid endometrial adenocarcinomas and 29 microdissected normal endometrium specimens using the Affymetrix Human U133 Plus 2.0 oligonucleotide microarray. Selected genes of interest were validated by quantitative real-time-polymerase chain reaction (qRT-PCR). Pathway analysis was performed to reveal gene interactions involved in endometrial tumorigenesis. Unsupervised hierarchical clustering displayed a distinct separation between the endometrioid adenocarcinomas and normal endometrium samples. Supervised analysis identified 117 highly differentially regulated genes (≥4.0-fold change), which distinguished the endometrial cancer specimens from normal endometrium. Twelve novel genes including DKK4, ZIC1, KIF1A, SAA2, LOC16378, ALPP2, CCL20, CXCL5, BST2, OLFM1, KLRC1 and MBC45780 were deregulated in the endometrial cancer, and further validated in an independent set of 56 cancer and 29 normal samples using qRT-PCR. In addition, 10 genes were differentially regulated in late-stage cancer, as compared to early-stage disease, and may be involved in tumor progression. Pathway analysis of the expression data from this tumor revealed an interconnected network consisting of 21 aberrantly regulated genes involved in angiogenesis, cell proliferation and chromosomal instability. The results of this study highlight the molecular features of endometrioid endometrial cancer and provide insight into the events underlying the development and progression of endometrioid endometrial cancer.

AB - Endometrial cancer is the third most common gynecologic malignancy and the ninth most common malignancy for females overall in Hong Kong. Approximately 80% or more of these cancers are endometrioid endometrial adenocarcinomas. The aim of this study was to reveal genes contributing to the development of endometrioid endometrial cancer, which may impact diagnosis, prognosis and treatment of the disease. Whole-genome gene expression analysis was completed for a set of 55 microdissected sporadic endometrioid endometrial adenocarcinomas and 29 microdissected normal endometrium specimens using the Affymetrix Human U133 Plus 2.0 oligonucleotide microarray. Selected genes of interest were validated by quantitative real-time-polymerase chain reaction (qRT-PCR). Pathway analysis was performed to reveal gene interactions involved in endometrial tumorigenesis. Unsupervised hierarchical clustering displayed a distinct separation between the endometrioid adenocarcinomas and normal endometrium samples. Supervised analysis identified 117 highly differentially regulated genes (≥4.0-fold change), which distinguished the endometrial cancer specimens from normal endometrium. Twelve novel genes including DKK4, ZIC1, KIF1A, SAA2, LOC16378, ALPP2, CCL20, CXCL5, BST2, OLFM1, KLRC1 and MBC45780 were deregulated in the endometrial cancer, and further validated in an independent set of 56 cancer and 29 normal samples using qRT-PCR. In addition, 10 genes were differentially regulated in late-stage cancer, as compared to early-stage disease, and may be involved in tumor progression. Pathway analysis of the expression data from this tumor revealed an interconnected network consisting of 21 aberrantly regulated genes involved in angiogenesis, cell proliferation and chromosomal instability. The results of this study highlight the molecular features of endometrioid endometrial cancer and provide insight into the events underlying the development and progression of endometrioid endometrial cancer.

KW - Endometrioid endometrial cancer

KW - Gene expression profiling

KW - Signaling pathway

UR - http://www.scopus.com/inward/record.url?scp=33947507141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947507141&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1209986

DO - 10.1038/sj.onc.1209986

M3 - Article

C2 - 17043662

AN - SCOPUS:33947507141

VL - 26

SP - 1971

EP - 1982

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 13

ER -